FDA will fast track review of nonsteroidal treatment option for giant cell arteritis.
Patients experienced an elevated risk of venous thromboembolism both immediately before and immediately after giant cell arteritis diagnosis.
A retrospective analysis has shown that patients with ANCA-associated vasculitis treated with rituximab have a much lower risk of developing subsequent malignancies when compared with those treated with cyclophosphamide.
Treatment of giant cell arteritis or granulomatosis with polyangiitis with prednisolone or prednisone has been linked to elevated risks of type 2 diabetes early during treatment.
Tocilizumab (Actemra®,Genentech) is the first treatment proposed for giant cell arthritis in 50 years.
Distinctive presentations, histopathology, and therapeutic response in both KD and KLS suggest a common etiology.
Retrospectively acquired population-based data suggest that the incidence of VTE, stroke and TIA was similar in patients with GCA compared to those who did not have GCA.
Low IgG and B cell counts were associated with infection and vaccine response among patients with systemic vasculitis in stable remission.
Measuring IgG levels and B cell counts may identify high infection risk and help clinicians balance the risk of immunosuppression side effects and disease activity in patients with systemic vasculitis.
This is the first randomized placebo-controlled trial to demonstrate the induction and remission efficacy of IL-6 inhibition with tocilizumab in patients with giant cell arteritis (GCA).
Rheumatology Advisor Articles
- FDA Clears Radiofrequency Treatment for Osteoarthritis Knee Pain
- Osteoporosis Treatment Receives Updated Guidelines From ACP
- Six Institutional Areas Tied to Physician Burnout
- Assessing the Diagnostic Accuracy of MRI in Early Rheumatoid Arthritis
- Superior Reduction in Osteoarthritis Knee Pain From Novel Hyaluronan Injection
- Knee Osteoarthritis: Intra-Articular Triamcinolone vs Saline Injection
- Knee Pain Relief From Fiber, Chondroitin in Osteoarthritis
- Bone Mineral Density Changes Related to Adrenal Incidentalomas in Menopause
- Patients Satisfied With Telemedicine Primary Care Visits
- HIV-Induced Osteoporosis Detected Via Bone Ultrasonography